Partnerships

Commercialization opportunities for pharmaceutical partners

ALK-ABELLÓ

Commercial Partner

A global allergy solutions company, ALK supports a wide range of allergy treatments, services, and products that meet the needs of allergy sufferers around the world.

ALLERGY PARTNERS, PLLC

Investor & Strategic Partner

With over 175 providers in 20 states, Allergy Partners, P.A. is the largest allergy, asthma, and immunology practice in the United States.

MOLEX VENTURES

Investor & Strategic Partner

A Koch Industries subsidiary, Molex is a globally recognized provider of multi-dimensional, cross-industry solutions.

UNIVERSITY OF MINNESOTA TWIN CITIES

$3.2 Million Grant Sponsored by the National Institutes of Health

Windgap received NIH funding to help develop an IM, wet/dry autoinjector that can rescue fire victims and first responders from cyanide exposure due to smoke inhalation.

University of Minnesota Twin Cities partners with Windgap Medical

Close the gap between what’s possible and what’s next.

We are actively seeking partnerships that can employ our innovative wet/dry medical technology to improve and save lives.

Explore our future impact on: